
Teva Pharmaceutical Industries Ltd. (NASDAQ:
Manufactured by GlaxoKleinSmith, the patent for Valtrex expires in December and final approval for the generic version is expected at that time. Mylan Laboratories Inc. (NYSE:
« Tentative FDA Approval for Generic Zyrtec Chewable | Main | Advertising Prescription Drugs Bad says Europe Experts »
|
Oct 5
|
![]() Teva Pharmaceutical Industries Ltd. (NASDAQ: Manufactured by GlaxoKleinSmith, the patent for Valtrex expires in December and final approval for the generic version is expected at that time. Mylan Laboratories Inc. (NYSE:
|
TrackBack URL for this entry:
« Tentative FDA Approval for Generic Zyrtec Chewable | Main | Advertising Prescription Drugs Bad says Europe Experts »
Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!
BIZZlogos - Add your logo - free link to your site| View Network Map Network Feed List (OPML) Know More Media Network Feed |
PharmaGazette is a member of the Know More Media network of business related blogs.
Here are some current headlines from some of our business publications:
ProductivityGoal | CallCenterScript |
AdHurl | TheBizofKnowledge |
LandingTheDeal | CustomersAreAlways |
HealthCareVox | BrainBasedBusiness |
TheInsurancePolicy | MarketingBlurb |
Comment Preview